Intuitive Surgical Stock Climbs After Company Tops Q4 Earnings - Intuitive Surgical (NASDAQ:ISRG)

Intuitive pushes into cardiac robotic surgery, ASCs

The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping up its presence in ambulatory surgery centers.

This Often-Overlooked Growth Stock Just Reported An Amazing Quarter. Time to Buy Shares?

Key PointsThe surgical robotics company's procedure growth remained impressive, supporting recurring revenue.Intuitive Surgical's Da Vinci 5 adoption is ramping quickly.Sales of Ion are growing faster than its core Da Vinci platform.10 stocks we like better than Intuitive Surgical › Shares of Intuitive Surgical (NASDAQ: ISRG) rose in after-hours trading on Thursday after the surgical robotics specialist reported fourth-quarter results that showe…

Intuitive Surgical outlines 13–15% da Vinci procedure growth for 2026 as global expansion accelerates

Intuitive Surgical Stock Climbs After Company Tops Q4 Earnings - Intuitive Surgical (NASDAQ:ISRG)

Intuitive Surgical Inc (NASDAQ:ISRG) reports financial results for the fourth quarter on Thursday. Here's a rundown of the report.

Intuitive Surgical receives FDA clearance for non-force feedback instruments in cardiac procedures

The US Food and Drug Administration (FDA) has cleared non-force feedback instruments used with Intuitive's da Vinci 5 robot in cardiac procedures, the company’s CEO has said.The post Intuitive receives FDA clearance for non-force feedback instruments in cardiac procedures appeared first on Medical Device Network.

Intuitive Surgical (NASDAQ:ISRG) Lowered to “Hold” Rating by Zacks Research

Zacks Research cut shares of Intuitive Surgical (NASDAQ:ISRG – Free Report) from a strong-buy rating to a hold rating in a report issued on Wednesday morning,Zacks.com reports. ISRG has been the topic of several other reports. Barclays reiterated an “overweight” rating and issued a $686.00 price objective (up from $635.00) on shares of Intuitive Surgical […]